Dang, Q., Li, L., Xie, H., He, D., Chen, J., Song, W., . . . Chang, C. (2015). Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Mol Oncol.
Citação norma ChicagoDang, Qiang, et al. "Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation Via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals." Mol Oncol 2015.
Citação norma MLADang, Qiang, et al. "Anti‐androgen Enzalutamide Enhances Prostate Cancer Neuroendocrine (NE) Differentiation Via Altering the Infiltrated Mast Cells → androgen Receptor (AR) → miRNA32 Signals." Mol Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.